14 May Invizius announces successful Series A financing to develop anti-inflammatory treatment for haemodialysis
(Left to right) Dr Magnus Nicolson, COO; Richard Boyd, CEO; Eric Beard, Chairman; Dr Andy Herbert, CTO; James Robson, CFO £5.3 million financing to complete First-in-Man safety study Led by Mercia, Downing Ventures, Old College Capital, Scottish Enterprise and Solvay Ventures; welcomes new investors Calculus...